PRINCETON, N.J., Aug. 25 /PRNewswire/ -- Novo Nordisk announced today the availability of NovoDose™– the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood ...
Kirsty 100units/mL is supplied as a 3mL single-patient-use prefilled pen as well as a 10mL multiple-dose vial. The approval of insulin aspart-xjhz was supported by a comprehensive data package that ...
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
Novolog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]), a dual-action insulin analog that does not contain NPH insulin, is more effective in ...
FDA Approves Novo Nordisk NovoLog Category Change For Use In Pregnant Women With Type 1 Diabetes PRINCETON, N.J., Jan. 30 -- Novo Nordisk announced today that the United States Food and Drug ...
Novo Nordisk announced that the FDA has approved its insulin aspart injection Fiasp, which can rapidly improve glycemic control at mealtimes for patients with type 1 and type 2 diabetes. Novo Nordisk ...
The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to enhance glycemic control in adults and children with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback